INTRODUCTION
cognitive impairment, MCI, Alzheimer’s disease, debilitating disorder, cognitive decline, AD
Alzheimer’s disease (AD) is a debilitating disorder that affects approximately 6 million people in the United States and 50 million people worldwide [Mild cognitive impairment (MCI), a formal diagnosis that includes measures of both objective cognitive impairment (OCI) and subjective cognitive decline, is a known predictor for developing AD [The goals of the research presented here were to explore a multimodal, individualized medicine approach to OCI, extending participation to those with AD. The primary aims of the pragmatic interventional trial presented here were to: describe a model of multimodal, individualized medicine approach for the treatment of OCI; and, to collect preliminary data on before and after changes in validated cognitive function instruments.